Clinical Trial Enzyme Application Targeting Venous Leg Ulcers
Status:
Recruiting
Trial end date:
2022-04-10
Target enrollment:
Participant gender:
Summary
This is an open-label, first-in-human (Phase IIa) study designed to assess the safety (and
efficacy) of Aurase Wound Gel, an enzymatic debridement product, intended for topical
application to sloughy venous leg ulcers (VLU).